Special Session on
Applications of AI Methods
Written by Ameen Abu-Hanna
FOR PAPERS FOR THE SPECIAL SESSION ON APPLICATIONS
Much of the literature on AI in Medicine pertains to the
question “Does the system work?” while the questions “Does it
help?” and “Why it succeeds or fails?” receive far less
attention. This session is dedicated to two kinds of papers addressing these
latter two questions. In particular the following types are sought:
1. Papers on substantial fielded applications. The paper should attempt to
demonstrate that the application actually improves clinical care. The
applications should meet one or (preferably) more of these criteria:
* the application addresses a non-trivial
problem which affects a substantial number of people.
* the application’s impact has been
subjected to adequate validation (ultimately by interventional multicentre
* the impact affects a relevant process (e.g.
behavior of care professionals) or outcome of care (e.g. adverse events).
* the application has been integrated into the
clinical workflow and IT infrastructure and adopted in daily clinical practice.
2. Papers on important lessons learned by research teams developing and
implementing applications or series of applications in clinical practice.
Application papers should not (only) present concrete application results; they
are primarily meant to convey insight obtained during research on real
applications for non-trivial problems. One should describe general lessons
learned e.g. about the nature of working with clinicians; integrating an
application with an existing information infrastructure; barriers experienced
such as resistance to the application or reasons for success or failure; the
difference in experience between implementing a prototype and an implementation
meant for a longer term, etc.
Regardless of the paper type please address the relevant
points from the following list:
Clinical/medical setting, patient/client population, the perceived need for the
application, the problem owner, the initiator of the project (research group?
Clinicians?), the sponsor, the initial intended scope (prototype for research
or fielded application), the progress of implementation, the publication strategy.
Requirement elicitation, approach for developing the application, the interface
with the clinical/medical counterpart, motivation for the chosen development
environment, arrangements to accessing the information infrastructure,
application maintenance, plans for collecting data for future or ongoing
learned (the most important part of the paper): Design and
results of the (clinical) trials, factors of success and experienced barriers,
lessons learned, do’s and don’ts, what would you do differently in
1. Authors should specifically submit to this track (the submission
system will provide a way to indicate this).
2. Only long papers should be submitted in order to adequately assess
their merit. The length and layout of the papers in the track is exactly the
same as any other AIME paper.
3. The papers are initially reviewed for this track by the session
4. Dates for notification are the same as for the other papers.
5. Papers in this session, like the other AIME papers are eligible for
selection in the planned journal special issue.
Updated on Tuesday, 11 May 2010 07:00